Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 100,000 shares at $70.50 ($7.0M) on 2021-12-10, disclosed to the SEC on 2021-12-14.
Open-market sale of $7.0M KRYS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |